Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00726271 · ClinicalTrials.gov registry record · NA
Pilot Study of Dietary Modification of Appetite Set Point in Obesity
A NA study, sponsored by State University of New York - Upstate Medical University.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT00726271 is a NA study that was terminated before completion, run by State University of New York - Upstate Medical University. The registered enrollment target is 50 participants.
The verdict
NCT00726271, a NA study, was terminated before completion, sponsored by State University of New York - Upstate Medical University.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
An innovative dietary approach to obesity, based on the set-point theory of body weight and associative learning, was developed by Seth Roberts. Roberts's approach focuses on dissociating flavor and calories by consuming small amounts of very bland but calorie-dense foods such as extra-light olive oil between meals. Roberts believes that the dissociation between flavor and calories lowers the body weight's set point, suppressing appetite and thereby inducing weight loss without causing hunger. Studying the feasibility of this approach is particularly relevant to patients taking drugs that cause increased appetite and weight gain as a side effect, as increased hunger makes the usual calorie restriction approach even more difficult than it normally is. Low-income people have a diet higher in prepackaged standardized foods, which may be one contributing factor to their higher risk of developing obesity. Specific Aims * To test the acceptance of, and the patients' compliance rate to, the Shangri-La Diet * To ascertain whether a controlled clinical trial of the Shangri-La Diet would be feasible. * To see if the weight loss documented anecdotally in many people is reproducible in patients from low-income areas who are overweight and taking prescribed medications associated with increased appetite and weight gain. Analysis: The primary end point will be acceptability of the dietary intervention as measured by the final interview and the evaluation form-is this something patients would be willing to do over the long term? This will help determine whether a controlled trial of the dietary intervention would be feasible, and provide information needed to design such a trial. Secondary outcomes will be changes in the participants' weight, waist measurements, anxiety, and depression scores
Interventions
- DIETARY_SUPPLEMENT light olive oil, fish oil capsules, flax seed oil capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2008-06 |
| Est. Completion | 2008-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00726271
The ClinicalTrials.gov registry entry for NCT00726271 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which light olive oil, fish oil capsules, flax seed oil capsules is the first listed.
NCT00726271 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00726271 about?
NCT00726271 is a clinical study titled "Pilot Study of Dietary Modification of Appetite Set Point in Obesity". An innovative dietary approach to obesity, based on the set-point theory of body weight and associative learning, was developed by Seth Roberts. Roberts's approach focuses on dissociating flavor and calories by consuming small amounts of very bland but calorie-dense foods such as extra-light olive o...
What is the current status of trial NCT00726271?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2008-06. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00726271?
The interventions under investigation include: light olive oil, fish oil capsules, flax seed oil capsules (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT00726271?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.